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The endemic Croatian species Centaurea ragusina L., like other species from the genus
Centaurea, has been traditionally used in Croatia as an antibacterial agent and for the
treatment of gastrointestinal and urogenital disorders. In several chromatographic steps,
three flavonoids and three sesquiterpene lactones (STLs) were isolated and identified
from the most active fractions of the ethanol extract. Two STLs, one for which we
created the trivial name ragusinin, and hemistepsin A are here reported for the first
time as constituents of the genus Centaurea. All six compounds were screened for
their effect on several tumor and one normal cell lines. Among them, ragusinin showed
the best bioactivity and high specificity to affect tumor murine SCCVII, human HeLa
and Caco-2 cell lines, but not the viability of normal V79 fibroblasts. Due to these
characteristics the action of ragusinin was investigated in more detail. Since DNA is
the primary target for many drugs with antibacterial and anticancer activity, we studied
its interaction with ragusinin. Rather moderate binding affinity to DNA excluded it as
the primary target of ragusinin. Due to the possibility of STL interaction with glutathione
(GSH), the ubiquitous peptide that traps reactive compounds and other xenobiotics to
prevent damage to vital proteins and nucleic acids, its role in deactivation of ragusinin
was evaluated. Addition of the GSH precursor N-acetyl-cysteine potentiated the viability
of HeLa cells, while the addition of GSH inhibitor L-buthionine sulfoximine decreased
it. Moreover, pre-treatment of HeLa cells with the inhibitor of glutathione-S-transferase
decreased their viability indicating the detoxifying role of GSH in ragusinin treated cells.
Cell death, derived by an accumulation of cells in a G2 phase of the cell cylce, was
shown to be independent of poly (ADP-ribose) polymerase and caspase-3 cleavage
pointing toward an alternative cell death pathway.
Keywords: Centaurea, sesquiterpene lactones, DNA, cell viability, toxicity, glutathione
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INTRODUCTION
The genus Centaurea (Asteraceae) represents an attractive
source for bioactive secondary metabolites such as sesquiterpene
lactones (STLs), flavonoids, lignans, and their glycosides
(Khammar and Djeddi, 2012). A number of therapeutic effects
against microbial infections, gastrointestinal disorders, and
urogenital ailments have been attributed to Centaurea species in
Croatian folk medicine and worldwide (Pahlow, 1989; Ayad et al.,
2012; Politeo et al., 2012).
Our recent study on the phytochemical and bioactive profile
of non-volatile constituents of Centaurea ragusina L., an endemic
Croatian halophytic species (Radić et al., 2013), indicated the
strong potential for obtaining bioactive compounds from the leaf
ethanol extract (CRE) (Vujčić et al., 2017).
In continuation of this previous study, the aim was to
investigate the biological activity of all isolated compounds,
namely the interaction with DNA, the antibacterial activity
against Gram-positive (Staphylococcus aureus) and Gram-
negative bacteria (Acinetobacter baumannii) (Lee et al., 2007;
Ćurković-Perica et al., 2015) and anticancer activity against a
panel of murine and human cancer cells.
Due to its high biological significance, DNA is the primary
target for many drugs with antibacterial and anticancer activity.
Small organic molecules can bind to DNA by means of a
non-specific, electrostatic binding along the DNA backbone, a
specific groove binding and intercalation or can form crosslinks
with DNA strands and induce cleavage of the DNA backbone
(Demeunynck et al., 2002; Sangeetha Gowda et al., 2014).
STLs are known to bind covalently to sulfhydryl groups of
enzymes and other functional proteins by Michael type addition
of their electrophilic α, β-unsaturated carbonyl structures. It is
believed that most of STL biological effects are due to their
reaction with biological nucleophiles such as GSH (Kupchan
et al., 1971; Picman, 1986; Schmidt, 1999). Among many roles of
GSH in the cell, the most important one seems to be the removal
of reactive species and elimination of xenobiotic compounds. The
last one can be accomplished through conjugation with GSH
followed by secretion of adducts from the cell (Boyland and
Chasseaud, 1969).
Here, the aim was to study the activity of the most bioactive
compound in more detail, which included the interaction with
DNA as the potential primary target and the interaction with
GSH and its impact on cytotoxicity, cell cycle and cell death.
MATERIALS AND METHODS
All safety precautions were taken when working with chemicals
reagents used in the experiments.
General Experimental Procedures
1D and 2D NMR experiments were performed on an Avance
500 MHz instrument equipped with cryoprobe (Bruker,
Billerica, MA, United States). The samples were measured in
MeOD and DMSO-d6, respectively (calibrated to the residual
non-deuterated solvent signals). HR-ESI-MS analyses were
performed on a maXis HD ESI-Qq-TOF mass spectrometer
(Bruker Daltonics, Bremen, Germany). The ESI ion source was
operated as follows: capillary voltage: 2.0 to 4.5 kV (individually
optimized), nebulizer: 0.4 bar (N2), dry gas flow: 4 L min−1 (N2)
and dry temperature: 200◦C, scanning range, m/z 50–1550. For
each isolated compound, fragment ion spectra of the [M+H]+,
the [M+Na]+ and either the [M-H] − or the [M+HCOO]− ion
were recorded. The sum formulas of the ions were determined
using Bruker Compass DataAnalysis 4.2 based on the mass
accuracy (1m/z ≤ 2 ppm for MS1 and≤ 3 ppm for MS/MS) and
isotopic pattern matching (SmartFormula algorithm).
Column chromatography (CC) was performed using
Merck silica gel 60 (40–63 µm) and Pharmacia Sephadex
LH-20 (20–100 µm). The fractions obtained from all
chromatographic steps were analyzed by TLC (mobile phase:
CH2Cl2-EtOAc (85:15), n-hexane-EtOAc-CH3COOH (6:3:1),
or n-hexane-EtOAc (8:2); stationary phase: Merck silica gel
60 PF254, detected with staining reagents vanillin/H2SO4 at
vis, UV254, and UV366). HPLC was performed on a Shimadzu
UFLC-XR instrument (Kyoto, Japan) with a photodiode array
detector (DAD). LC-parameters: stationary phase: Phenomenex
Gemini-NX (C18), 150 mm × 3.00 mm, 5 µm; temperature:
35◦C; mobile phase: water with 0.1% formic acid (A); acetonitrile
(B); flow rate 0.4 mL/min; UV detection wavelength: 275 nm;
injection volume: 10 µL; gradient: 80/20 A/B in 5 min to 70/30
A/B, then within 20 min to 50/50 A/B and within another 2 min
to 2/98, followed by a 5 min column wash (2A/98B) and a
re-equilibration period of 10 min. All chemicals and solvents
used were of analytical grade.
Plant Material
Centaurea ragusina L. plants (in vegetative phase) were collected
in September, 2016, from two wild habitats – Katalinić brig
(43◦30′03′′N, 16◦26′40′′E, 363 m) and Sustipan (43◦30′04′′N,
16◦25′35′′E, 754 m), Split, Croatia and identified by M. Ruščić,
Department of Biology, University of Split, Croatia. A voucher
specimen (FSS-CR112016) is deposited at the above-mentioned
department.
For extract preparation and isolation of pure compounds,
lyophilized leaf materials from both locations were combined
after confirmation of their comparable metabolite profile (Vujčić
et al., 2017).
Extraction and Isolation
The dried ground leaves of C. ragusina L. (804.9 g) were
macerated with 7 L EtOH 96% (at 22◦C for 7 days). For an
exhaustive extraction the procedure was repeated three times.
The dried extract (CRE, 108.9 g) was roughly fractionated by
silica gel CC (Merck silica gel 60 PF254, 510 g; 5.5 cm × 56 cm)
using a step gradient of CH2Cl2-EtOAc-MeOH (CH2Cl2;
CH2Cl2-EtOAc 98:2; 95:5; 90:10; 85:15; 80:20; 75:25; 65:35; 60:40;
55:45; 45:55; 35:65; 25:75; EtOAc; EtOAc-MeOH 80:20; 60:40;
40:60; 20:80; MeOH) to give twelve fractions (A1–12).
Fraction A6 (2.9 g) was further separated using silica gel CC
(Merck silica gel 60 PF254, 213 g; 3 cm× 56 cm) applying again a
gradient system of CH2Cl2-EtOAc-MeOH to yield 25 fractions
(B1–25). Fraction B11 (91.6 mg) was purified via Sephadex
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LH-20 CC (mobile phase: MeOH) yielding eight fractions (C1–8).
Fraction C7 was obtained as 17.5 mg of compound 2 (oroxylin A).
Also Fraction B12 (76.4 mg) was purified via Sephadex LH-20 CC
(mobile phase: MeOH) yielding 14 fractions (D1–14). Fraction
D13 was obtained as 11.8 mg of compound 1 (chrysin).
Fraction B19 (939.8 mg) was subjected to silica gel CC
(Merck silica gel 60 PF254, 310 g; 3.3 cm× 63 cm) eluting with
the isocratic solvent system of n-hexane-EtOAc-CH3COOH
(6:3:1), yielding 14 fractions (E1–14). Fraction E9 (26.9 mg) was
further separated by means of a Sephadex LH-20 column (mobile
phase: MeOH) to give three fractions (F1–3). Fraction F2 was
obtained as 21.8 mg of compound 5 [(3aR,4S,6aR,8S,9aR,9bR)-
[dodecahydro-8-dihydroxy-3,6,9-tris(methylene)-2oxo-2(3H)-
azuleno[4,5-b]furanyl]-3-methyl-butanoate].
Fraction A8 (834.3 mg) was separated via a Sephadex
LH-20 column (mobile phase: MeOH) giving seven fractions
(G1-7). Fraction G7 was obtained as 80.3 mg of compound
3 (hispidulin). Fraction G4 (339.4 mg) was submitted to
passage over a Sephadex LH-20 column (mobile phase: CH2Cl2-
acetone, 85:15) to yield twelve fractions (H1-12). Fraction H10
(251.4 mg) was further separated using silica gel CC (Merck
silica gel 60 PF254, 150 g; 1.5 cm × 56 cm) applying again
a gradient system of n-hexane-EtOAc-CH3COOH (6:3:1 to
4:5:1) to yield ten fractions (I1-10). Fraction I9 (185.8 mg)
was subjected to a Sephadex LH-20 column (mobile phase:
MeOH) resulting in three fractions (J1-3). Fraction J1 (17.8 mg)
was purified by silica gel CC (Merck silica gel 60 PF254,
50 g; 1.5 cm × 35 cm) applying again a gradient system of
CH2Cl2-EtOAc-MeOH to yield two fractions (K1-2). Fraction
K1 was obtained as 3.4 mg of compound 4 (deacylcynaropicrin).
Fraction J2 (153.6 mg) was purified by preparative TLC (Merck
silica gel 60 PF254, 20 cm × 20 cm) and a solvent system
of n-hexane-EtOAc-CH3COOH (5:4:1) to yield three fractions
(L1-3). Fraction L2 (115.7 mg) was separated via a Sephadex
LH-20 column (mobile phase: MeOH) giving two fractions
(M1-2). Fraction M2 was obtained as 12.7 mg of compound 6
(hemistepsin A).
The physical and spectroscopic data of compounds 1 to 6
agreed with those published previously for chrysin, oroxylin
A, hispidulin, deacylcynaropicrin, [3aR,4S,6aR,8S,9aR,9bR)-
[dodecahydro-8-dihydroxy-3,6,9-tris(methylene)-2oxo-2(3H)-
azuleno[4,5-b]furanyl]-3-methyl-butanoate], and hemistepsin A
(Miyase et al., 1985; Zdero et al., 1989; Jang et al., 1999; Nagao
et al., 2002; Marques et al., 2010; Yang et al., 2013). Their purity
was checked using TLC and LC-MS and revealed to be > 98% in
all cases.
Spectroscopic Experiments for the
Determination of ctDNA Interactions
The electronic absorption spectra (UV/Vis) were recorded on a
Varian Cary 100 Bio spectrophotometer (Agilent, Santa Clara,
CA, United States) and circular dichroism (CD) spectra on a
JASCO J815 spectrophotometer (ABL&E Handels GmbH, Wien,
Austria) at 25◦C using appropriate 1 cm path quartz cuvettes
(Eriksson and Nordén, 2001). The calf thymus DNA (ctDNA)
was purchased from Sigma-Aldrich. Isothermal titration
calorimetry (ITC) experiments were performed on a MicroCal
VP-ITC microcalorimeter (MicroCal, Inc., Northampton, MA,
United States) (Chaires, 2006). Origin 7.0 software, supplied
by the manufacturer was used for data analysis. All additional
data of these experiments are provided in the Supplementary
Material.
Antibacterial Assay
Antibacterial activities of C. ragusina L. CRE extract, fractions
and isolated compounds against Gram-negative A. baumannii
Durn (Ćurković-Perica et al., 2015) and Gram-positive S. aureus
ATCC 25923 were tested using modified Clinical and Laboratory
Standards Institute (CLSI), broth microdilution (BD) using
2,3,5-triphenyltetrazolium chloride (TTC) (Lee et al., 2007). The
TTC-BD were performed according to the guidelines of the
CLSI using 96-well microplates (Clinical Laboratory Standards
Institute [CLSI], 2007). The bacteria were grown on nutrient
agar (Biolife, Milan, Italy) for 16 h at 36 ± 0.1◦C to obtain
the cultures in log phase of growth. The bacterial biomass was
then suspended in sterile NaCl (0.85% v/v) to give turbidity
equivalent to the McFarland 0.5 standard. Bacterial suspension
(0.1 mL) was transferred to a tube containing 9.1 mL nutrient
broth (Biolife) and 0.8 mL 0.05% TTC to give an inoculum
density of 1 × 106 Colony Forming Units (CFU)/mL. Minimum
inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC) values were determined in triplicates. The
final concentrations for MIC and MBC determination of samples
were 1.9–4000 µg/mL. Other data on antibacterial experiments
are available in the Supplementary Material.
Cytotoxicity Assays and Cell Death
Analysis
Crystal Violet (CV) Assay
Murine melanoma (B16F10) cell lines, human colon carcinoma
(Caco-2) and human breast carcinoma (MCF-7) cell lines were
purchased from American Type Culture Collection (ATCC,
Manassas, VA, United States), murine fibrosarcoma (FsaR) and
murine squamous cell carcinoma (SCCVII) cell lines were
obtained from BC Cancer Research Centre (Vancouver, Canada).
Cells were grown in a humidified atmosphere of 5% CO2,
at 37 ◦C in Roswell Park Memorial Institute (RPMI) 1640
medium supplemented with 10% fetal bovine serum (FBS)
(Sigma-Aldrich, St. Louis, MO, United States). As normal cell
line, the V79 fibroblasts derived from hamster’s lung tissue,
were used. CV protocol (Ivanković et al., 2015) is described in
Supplementary Material.
[3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium
Bromide] Tetrazolium Reduction (MTT) Assay
Ethacrynic acid (ETA; Sigma-Aldrich) was dissolved in
DMSO (Sigma-Aldrich) and kept at −20◦C. Buthionine
sulfoximine (BSO; Sigma-Aldrich) and N-acetylcysteine (NAC;
Sigma-Aldrich) were dissolved in water, 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide was purchased
by Sigma-Aldrich and dissolved in phosphate-buffered saline
and kept by 4◦C. Human cervical carcinoma HeLa cell line
was obtained from cell culture bank (GIBCO BRL-Invitrogen,
Waltham, MA, United States). The cells were grown as a
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monolayer culture in Dulbecco’s modified Eagle’s medium
(DMEM; Sigma-Aldrich), supplemented with 10% (FBS;
Sigma-Aldrich) in a humidified atmosphere of 5% CO2 at 37◦C
and were sub-cultured every 3–4 days. Cytotoxic activity of the
STL 5 was determined by MTT assay, an assay for assessing cell
viability based on its metabolic activity, modified accordingly
(Mickisch et al., 1990; also in Supplementary Material).
Cell Cycle and Cell Death Analysis
HeLa cells were seeded into tissue culture plates and treated
with different concentrations of the compound during 72 h.
Thereafter, both adherent and floating cells were collected,
washed with PBS and fixed overnight in 70% ethanol at –
20◦C. Fixed cells were treated with RNase A (0.1 mg/mL,
Sigma-Aldrich) for 1 h at room temperature and afterward
stained with propidium iodide (PI; 50 µg/mL, Sigma-Aldrich) for
30 min in the dark. In order to analyze the cell cycle progression,
the DNA content and PI staining were detected by flow cytometry
(FACS Calibur, BD Biosciences, San Jose, CA, United States).
Data were analyzed with ModFit LTTM program (Verity Software
House Inc., Topsham, ME, United States).
Twenty-four hours after the seeding, HeLa cells were treated
with 2, 5, and 10 µM of compound 5. After 48 h, both
adherent and floating cells were collected by centrifugation and
then washed with PBS. The cell suspension was incubated with
Annexin V (BD Biosciences; according to producer’s protocol)
and PI (5 µg/mL, Sigma-Aldrich). Upon 30 min incubation at
room temperature in the dark, the viable, early apoptotic, late
apoptotic/necrotic, and necrotic cell populations were detected
and counted by flow cytometry (BD Biosciences). Data were
analyzed with ModFit LTTM program (Verity Software House
Inc.).
In addition, the specific markers of programmed cell death
were determined, cleavage of Poly (ADP-ribose) polymerase-1
(PARP) and caspase-3, by western blot as described previously
(Brozovic et al., 2013). In short, the 2 h incubation at
room temperature with monoclonal anti-PARP (Santa Cruz
Biotechnology) and polyclonal anti-caspase-3 (anti-Cas-3;
Cell Signaling Technology, Danvers, MA, United States)
antibodies was performed. After washing with 0.01% Tween
20 in PBS and incubation with the corresponding horseradish
peroxidase-coupled secondary antibody (Amersham Pharmacia
Biotech, Munich, Germany), proteins were visualized with
ECL (Amersham Pharmacia Biotech) according to the
manufacturer’s protocol. All membranes were incubated with
anti-extracellular-signal-regulated kinases 1/2 (anti-ERK1/2)
(Santa Cruz Biotechnology) antibody to confirm equal protein
loading. ERK1/2 was used as loading controls since no changes
in total ERK1/2 expression were detected upon exposure of
cells to different drugs (Brozovic et al., 2004; Herraiz et al.,
2011).
Determination of Glutathione Function
The function of intracellular GSH in cell response to STL 5
was investigated by MTT assay. HeLa cells were either pre-
treated overnight with a specific inhibitor, 0.001 mM BSO or
for 2 h with a precursor in GSH synthesis, 5 mM NAC. Both
compounds are frequently used in the manipulation of GSH
level in the cells (Trachootham et al., 2009; Kannan et al.,
2014). Upon pre-treatment with either BSO or NAC, different
concentrations of STL 5 were added and the cytotoxicity effect
of the compounds was determined 72 h later as described
above.
The capacity of GSH to form the detoxification conjugates
through enzymatic reaction with STL 5 was investigated by
pretreatment of HeLa cells with of 5 µg/mL ETA for 2 h and
then with different concentrations of STL 5. The cell survival
was examined 72 h after. The optimal concentrations of used
modulators of GSH synthesis and glutathione S-transferase
reaction were determined previously (Osmak and Eljuga, 1993;
Brozovic et al., 2008; Brozovic et al., 2013).
Statistical Analysis
All results were evaluated using the software package Statistica
12.0 (StatSoft, Tulsa, OK, United States). Results were subjected
to one-way ANOVA for comparison of means and significant
differences were calculated according to Duncan’s multiple range
test. Data were considered statistically significant at P < 0.05.
Different letters indicate significant difference at P < 0.05.
RESULTS
Selection of Plant Material, Extraction,
Fractionation, and First Bioactivity
Assessment
As a starting point for phytochemical investigations, an ethanol
C. ragusina L. leaf extract (CRE) was prepared to obtain a
multicomponent mixture embracing a wide range of secondary
metabolites (Figure 1).
In antibacterial assays, CRE showed moderate antibacterial
effects against S. aureus with MIC of 500 µg/mL and MBC of
2000 µg/mL, respectively, and weak activity against A. baumannii
with MIC and MBC values both of > 4000 µg/mL, respectively
(Vujčić et al., 2017).
In contrast to the moderate antibacterial activity, CRE
exhibited significant effects on all tested murine melanoma
(B16F10), squamous cell carcinoma (SCCVII) fibrosarcoma
(FsaR) cell lines and normal hamster fibroblasts (V79).
At a CRE concentration of 60 µg/mL, the cell survival
relative to the negative control was ≤ 10% for V79 fibroblasts,
SCCVII and FsaR, respectively, and 21% for the B16F10. CRE
did not show selective cytotoxicity between murine cancer and
normal cell lines, which may be a consequence of a cumulative
effect of different bioactive compounds included in the crude
extract.
For a more focused isolation process of the bioactive
constituents of the crude extract, twelve fractions (A1–A12)
obtained by separation of CRE via silica gel chromatography
were retested in the mentioned cell lines, revealing A6 and A8
as fractions with the strongest cytotoxic activity. Both fractions
(60 µg/mL) exhibited stronger cytotoxic activity on B16F10
(< 10% cell survival) and SCCVII (≤ 20% cell survival) cell
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FIGURE 1 | HPLC analysis of the ethanol C. ragusina L. leaf extract (CRE) at 254 nm (for LC parameters see section “Experimental”).
lines compared to the moderate activity observed toward FsaR
and V79 cells (≤ 30% cell survival). Based on these results,
fractions A6 and A8, were selected for further chromatographic
separations.
Isolation and Identification of Pure
Compounds
Six constituents were isolated from CRE fractions A6 and A8 by
separation techniques including CC and preparative thin layer
chromatography.
By using HR-ESI-MS analyses and NMR experiments,
and by comparison with earlier studies (Miyase et al.,
1985; Zdero et al., 1989; Jang et al., 1999; Nagao et al.,
2002; Marques et al., 2010; Yang et al., 2013), the isolates
(Figure 2) were identified as chrysin (1), oroxylin A (2),
hispidulin (3), deacylcynaropicrin (4), (3aR,4S,6aR,8S,9aR,9bR)-
[dodecahydro-8-dihydroxy-3,6,9-tris(methylene)-2oxo-
2(3H)-azuleno[4,5-b]furanyl]-3-methyl-butanoate (5), and
hemistepsin A (6). Instead of using the complicated and long
systematic name for compound 5, we created the trivial
name ragusinin. The flavonoids (1–3) can be classified
as flavones, whereby different substitution patterns with
methoxy or hydroxy groups can be observed on C-6 and
C-4′. Compounds 4–6 are STLs belonging to the subtype of
guajanolides.
FIGURE 2 | Chemical structures of isolated C. ragusina L. leaf constituents.
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Compound 1 is a frequently occurring flavone reported as a
constituent of several Centaurea species (Mouffok et al., 2012).
However, we are reporting here for the first time its isolation
from C. ragusina L. Different bioactivities have been reported
for compound 1. It suppresses inducible nitric oxide synthase,
cyclooxygenase-2 expression and inhibits NF-κB activation,
which altogether leads to anti-inflammatory effects (Feng et al.,
2014). Compound 1 is also reported as a tumor cell growth
arrest compound, arresting C6 glioma cells in the G1 phase of
the cell cycle either through activating p38-MAPK leading to
the accumulation of p21Waf1/Cip1 protein or mediating the
inhibition of proteasome activity (Weng et al., 2005). It also
suppresses tumor growth of anaplastic thyroid cancer ATC cells
both in vitro and in vivo (Yu et al., 2013).
Compound 2 is known as the main component of several
medicinal plants including Oroxylum indicum (Krueger and
Ganzera, 2012) and various Centaurea species. However, so
far it has not been reported for C. ragusina L. Compound 2
was shown to activate caspase-3 and caspase-9 in human colon
carcinoma HCT-116 cells and decrease tumor volume and weight
in immunodeficient mice that were inoculated with HCT-116
cells (Hu et al., 2012). It also exhibits anti-inflammatory effects
by decreasing pro-inflammatory cytokines mediated by estrogen
receptor activity (Wang et al., 2013).
Compound 3 has been isolated from various Centaurea
species, e.g., C. melitensis L. (Negrete et al., 1989), C. aspera L.
(Ferreres et al., 1980), and C. jacea L. (Forgo et al., 2012), but
never from C. ragusina L. It is an important compound used in
traditional Chinese medicine for the treatment of liver carcinoma
(Gao et al., 2014). Besides an apoptotic effect on human liver
cancer HepG2 cells, it was also shown that this effect is mediated
via mitochondrial dysfunction (Gao et al., 2014). Furthermore,
an anti-proliferative effect toward human lung cancer A-549 cells
was reported for compound 3 (Zhang et al., 2012).
Compound 4 has already been reported as a constituent of
C. ragusina L. (Mahmoud et al., 1986) and other Centaurea
species with anti-inflammatory and cytotoxic activity (González
et al., 1977; Sosa et al., 2011).
To the best of our knowledge, guajanolides 5 and 6 have
never been identified as constituents from Centaurea species
before. Whereas for 6 an antibacterial and cytotoxic activity
toward human cell lines in the low µM range has previously
been reported (Jang et al., 1999) compound 5 (ragusinin) with
its isovalerate residue is a rare STL without reports on bioactivity.
Study of Biological Activity (Interactions
With DNA, Antibacterial and Cytotoxic
Activity) of C. ragusina L. Constituents
The DNA binding affinity of compounds is important to explore
since the DNA represents a well-known target of several broadly
used drugs and the binding to DNA is one of the common
causes of cell death (Demeunynck et al., 2002; Sangeetha Gowda
et al., 2014). In order to determine the binding affinity of the
isolated compounds to ctDNA, UV/Vis spectroscopy and ITC
(Bronowska, 2011) were employed (see section “Experimental”
and “Supplementary Material for details”). CD was used for
monitoring of conformational changes of ctDNA induced by
small molecule binding and for gaining information about modes
of interaction (Cantor and Schimmel, 1980; Johnson, 1994).
Among isolated STLs and flavonoids (Supplementary
Material), only 5 exhibited significant changes in CD titrations
(Supplementary Figure S4). Due to that reason, we decided to
characterize the binding of DNA only with compound 5. UV/Vis
spectroscopy was not applicable in the study of DNA-ragusinin
interaction due to absorption of STLs at short wavelengths
(210–220 nm). Therefore, the binding interaction of 5 with
ctDNA was monitored by ITC.
The ITC experiment of 5 with ctDNA resulted in negative
peaks indicating that the binding process was exothermic
(Figure 3). The resulting values were fitted to a single-site binding
model by the non-linear least square method yielding rather
moderate binding constant (log Ka = 4.04). The stoichiometry
(N) was fixed to 0.5 based on results from CD titration with
ctDNA (the saturation of binding sites was reached at the
ratio, r = 0.5, Supplementary Material). The binding of 5 to
ctDNA was characterized by a positive binding entropy (T1rS/kJ
mol−1 = 18.5) accompanied by smaller negative enthalpy
(1rH/kJ mol−1 = -4.6) revealing that its binding is entropically
driven. In many cases, the groove binding is associated with
positive (favorable) binding entropies due to the release of
FIGURE 3 | Calorimetric titration of compound 5 (c = 3 × 10−5 mol dm−3)
with ctDNA (c = 1.5 × 10−3 mol dm−3) in sodium cacodylate buffer (pH 7.0,
I = 0.05 mol dm−3; T = 25◦C; 1rG/kJ mol−1 = -23.0). The top panels
represent the raw data from the single injection of ctDNA into a solution of 5
and the bottom panels show the experimental injection heats while the solid
lines represent the calculated fit of the data.
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FIGURE 4 | Percentage of cell survival of rodent (V79, SCVII, B16F10, and FsaR) and human (Caco-2, HeLa, and MCF-7) cell lines after exposure to isolated
flavonoids (compounds 1–3), at concentrations of 10 µM (gray bars) and 5 µM (white bars). Values represent mean of 3 replicates ± SD. Different letters indicate
significant difference at p < 0.05. The dashed line indicates inhibition of cell growth by 50%. The positive control is 5-fluorouracil and the negative control are cells
without the tested samples.
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FIGURE 5 | Percentage of cell survival of murine (V79, SCVII, B16F10, and FsaR) and human (Caco-2, HeLa, and MCF-7) cell lines after exposure to
deacylcynaropicrin (4), ragusinin (5) and hemistepsin A (6) at concentrations of 10 µM (gray bars) and 5 µM (white bars). Values represent means of three
replicates ± SD. Different letters indicate significant difference at p < 0.05. The dashed line indicates inhibition of cell growth by 50%. The positive control is
5-fluorouracil and the negative control are cells without the tested samples.
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FIGURE 6 | Survival of HeLa cells following treatment with ragusinin (5). The
cells were treated for 72 h with different doses of 5. The MTT assay was
performed. Each point represents the mean of quadruplicates ± SD. Different
letters indicate significant difference at p < 0.05. The experiment is performed
at least three times.
confined or interfacial water molecules to the bulk (Perozzo et al.,
2004; Chaires, 2006).
Two STLs 5 and 6 were found to be the most active
ones reducing the growth of S. aureus with a MIC value of
31.3 µg/mL (Supplementary Table S1). However, since the
cytotoxic activity of the isolated compounds was more prominent
than the antibacterial, we presented here cytotoxic activity in
more detail while the data on antibacterial activity are available
in the Supplementary Material.
Crystal Violet (CV) bioassay, which measures the DNA mass
of living cells, was used for initial activity screening. The cytotoxic
effect of the isolated compounds 1 to 6 was monitored with the
CV test for 24 h at 5 and 10 µM on a panel of three murine
and three human cancer cell lines. 5-Fluorouracil was used as
a positive control at equimolar concentrations as the studied
compounds (Figures 4, 5). The isolated flavonoids 1 and 2 did
not demonstrate cytotoxic activity against the majority of cancer
cell lines at the applied concentrations. Only compound 3 exerted
a noticeable cytotoxic effect against HeLa cells (Figure 4). Among
the isolated STLs, 5 showed the most prominent cytotoxic
activity. In particular, compound 5 reduced the cell survival of
SCCVII cells to 42% at 10 µM and 50% at 5 µM concentration
(Figure 5). It also exhibited promising activity against Caco-2
cells at 10 µM and HeLa cells at both concentrations applied
(Figure 5). On the other hand, 5 had weak (cell survival was
85% at 10 µM) or no activity (> 95% at 5 µM) against
normal fibroblasts (V79). Moreover, while compound 4 did not
show significant cytotoxic effects on any cell line at the applied
concentrations, compound 6 showed noticeable effects against
SCVII and FsaR cells at 10 µM.
Cytotoxic Activity of Ragusinin (5) in
HeLa Cell Line
In order to determine the biological effect of the most active
compound 5 (Figure 5) in more detail, we used MTT assay and
HeLa cells as experimental model (Cimbora-Zovko et al., 2011).
Ragusinin decreased cell survival of HeLa cells in a
concentration-dependent manner in comparison to untreated
cells (Figure 6). The dose that killed 50% of the cell population
(IC50 value) after 72 h of continuous treatment with 5 was
between 1.8 and 2.3 µM (Figure 6).
To better understand the mechanism underlying the cell
growth impairment by 5, the cell cycle progression was
investigated. HeLa cells were treated with increasing doses of
5 during 48 h. As shown in Figure 7A, compound 5 triggers
the accumulation of HeLa cells in the G2 phase of cell cycle.
Moreover, a compound 5 induced dose-dependent increase of
cells in the Sub G1 population indicates a ragusinin-triggered cell
death (Figure 7A). The same was confirmed by treatment of cells
with 10 µM of 5 during 24–72 h. Time-dependent accumulation
of HeLa cells in the G2 phase is detectable as well as time-increase
of cells in the Sub G1 phase of the cell cycle (Figure 7B).
In order to determine the type of cell death triggered by 5,
the cells were treated with increasing doses of the compound
and 48 h later, FACS-Annexin V/PI staining was performed.
Our results show a ragusinin-induced dose-dependent apoptosis
(Figure 7C). We then performed Western blot analysis of specific
cell death markers, PARP and caspase-3 cleavage, following
treatment with 1.25 and 2.5 µM of 5 for 24–72 h. The
obtained results were interesting since 5 did not induce PARP
(Figure 7D) and caspase-3 cleavage (Figure 7E). The assumed
caspase-independent cell death triggered by 5 was in addition
confirmed by measuring the absence of caspase activity 3/7 by
Caspase-Glo R© 3/7 Assay (data not shown). The occurrence of
caspase and PARP cleavage independent cell death indicates
some alternative cell death pathway described in the literature
to be triggered by a different type of cell stressors (Kroemer and
Martin, 2005; Tait and Green, 2008). This is the first example of
caspase independent cell death described for compound 5.
Role of Glutathione (GSH) in Protection
of Cells From Ragusinin (5)
We were further interested in the possible role of GSH as
a protector of cells in ragusinin-induced cell death. For that
purpose, HeLa cells were either pre-treated with 5 mM NAC,
the precursor for GSH synthesis, for 2 h prior to treatment
with compound 5 or overnight with a specific inhibitor of GSH
synthesis, i.e., 0.001 mM BSO. The conditions used were tested
previously to be effective (Brozovic et al., 2008; Brozovic et al.,
2014). The obtained data showed that an increased level of
GSH protects HeLa cells from ragusinin’s toxicity (Figure 8A).
At the same time, depletion of GSH decreased cell survival of
HeLa cells compared to cells treated with compound 5 only
(Figure 8B).
Due to the fact that GSH instills several vital roles within
a cell including antioxidation, maintenance of the redox state,
modulation of the immune response, and detoxification of
xenobiotics (Balendiran et al., 2004), we discussed first its possible
role as an antioxidant. It is known that the cytotoxicity of the
sesquiterpenes helenalin and cynaropicrin can be affected via
generation of intracellular reactive oxygen species (ROS) (Cho
et al., 2004; Jang et al., 2013). We examined that possibility for
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FIGURE 7 | Cell cycle progression and induction of cell death in HeLa cells following treatment with ragusinin (5). The cells were treated either with 2.5, 5, and
10 µM of compound 5 for 48 h (A) or with 10 µM during 24–72 h (B). Cell cycle analysis was performed by flow cytometry upon cell staining with PI. The
representative data of three independent experiments which yielded similar results are shown. The cells were either non-treated or treated with 2.5, 5, and 10 µM of
5. After 48 h and staining with Annexin V and PI, the cell death was measured by flow cytometry. The representative data of three independent experiments which
yielded similar results are shown. The statistical analysis of data for three independent experiments are presented as means of percentage of viable (V), early
apoptotic (EA), late apoptotic/necrotic (LA/N), and necrotic (N) cell populations ± standard deviation (C). 24–72 h after exposure to 1.25 and 2.5 µM of 5, protein
level of cleaved PARP (D) and activated (i.e., cleaved) caspase-3 (Cas 3) (E) and cleaved PARP was analyzed in whole cell extracts by Western blot analysis. ERK1/2
protein expression was used as internal protein loading control. The representative data of three independent experiments which yielded similar results are shown.
Zero or C, non-treated cells; PM, protein marker PageRuler Prestained Protein Ladder (Thermo Fisher Scientific, United States). FL1-H/Annexin V-FITC,
FL2-H/Propidium iodide.
ragusinin by pre-treating HeLa cells either with tempol or trolox,
two antioxidant compounds (Aliaga et al., 2003). Results showed
that antioxidants, as well as salubrinal (Brozovic et al., 2013), i.e.,
an inhibitor of endoplasmic reticulum stress, had no impact on
ragusinin’s toxicity (Supplementary Material, in Supplementary
Figure S6). Thus, we further explored the capability of 5 to reach
functional protein targets in living cells without being deactivated
by reaction with GSH. The combination treatment of HeLa cells
with the well-known inhibitor of glutathione S-transferase (GST)
ethacrynic acid (Osmak et al., 1998) (c = 5 µg/mL) decreased cell
survival compared to cells treated with 5 only (Figure 9). The data
imply the enzymatically regulated formation of a detoxification
complex between GSH and 5.
DISCUSSION
Among the isolates (1 to 6) from the traditionally used herbal
remedy C. ragusina L. leaves, we discovered an interesting
pharmacological profile for the rare guajanolides ragusinin (5)
and hemistepsin A (6). Compound 5 was only once described as
a constituent from the aerial parts of the Australian Helipterum
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FIGURE 8 | The role of GSH in ragusinin’s (5) toxicity. The cells were either pre-treated for 2 h with 5 mM NAC (A) or overnight with 0.001 mM BSO (B). After that,
the cells were treated with different concentrations of 5. 72 h later, an MTT assay was performed. Bars represent the mean of quadruplicates ± SD. Different letters
indicate significant difference at p < 0.05. All experiments were performed at least three times.
FIGURE 9 | The treatment of HeLa cells with ethacrynic acid (ETA). The cells
were pre-treated with 5 µg/mL ETA. Two hours later the cells were treated
with different concentrations of 5. 72 h later an MTT assay was performed.
Bars represent the mean of quadruplicates ± SD. Different letters indicate
significant difference at p < 0.05. All experiments were performed at least
three times.
maryonii S. Moore (Zdero et al., 1989) and is characterized by
an isovalerate residue in position C-9a; compound 6 has been
described previously as a constituent from leaves and flowers of
Hemisteptia lyrata Bunge (Jang et al., 1999).
Whereas both natural compounds showed no antibacterial
activity against the Gram-negative A. baumannii, they exhibited
moderate inhibitory activity against S. aureus ATTC 25923
(MIC value of 31.3 µg/mL, Supplementary Material). For
comparison, three STLs (13-acetylsolstitialin A, centaurepensin,
and chlorojanerin) isolated from the aerial parts of Centaurea
solstitialis L. ssp. solstitialis showed inhibitory activity against
standard S. aureus with MIC values of 16 µg/mL (Özçelik
et al., 2009). In line with these findings, we focused on a more
prominent cytotoxic activity of the isolated compounds and the
investigation of the mechanism of action of the most active
compound 5.
We investigated the binding of isolated compounds to DNA
since studying the interactions of compounds with potential drug
targets and the knowledge of their antiproliferative activity can
help in forming the hypothesis about the mechanism of action of
novel compounds.
The isolated flavonoids (1–3) exhibited only weak interactions
with DNA which may explain the absence of cytotoxic effects
against the majority of studied cell lines. The somewhat stronger
cytotoxic activity of flavonoids against HeLa cells can be ascribed
to interactions with biological targets other than DNA (Chen
et al., 2012). Compound 3 with the highest number of hydroxy
groups on the flavonoid skeleton exhibited the most pronounced
cytotoxic activity. This finding is in agreement with literature data
(Beutler et al., 1998; Jeong et al., 2007; Csupor-Löffler et al., 2009).
While there are numerous reports on DNA binding affinities
with flavonoids (Kanakis et al., 2005; Rusak et al., 2010), there
is little data on DNA binding interactions with sesquiterpenes
(Vujčić et al., 2007). Regarding the structure of 5 and literature
data (Gates, 2009; Chadwick et al., 2013), the interaction
with DNA can be achieved via noncovalent binding to
double-stranded DNA (dsDNA) or by alkylation of DNA
nucleophiles through reaction with the α-methylene-γ-lactone
group. Several studies on the reactivity of STLs toward OH-
or N-nucleophiles (Atta-ur-Rahman, 2011) and CD changes
which were not consistent with an alkylation effect (Agarwal
et al., 2014) (Supplementary Figure S4) do not support the
latter possibility. In addition, the -SH group was found to be
much more susceptible to alkylation by sesquiterpenes than other
nucleophiles (Gewirtz et al., 2007). A reasonable explanation
based on our results from ITC and CD is noncovalent binding
of 5 most probably inside a hydrophobic interior of the DNA
groove. Due to its rather moderate binding affinity to ctDNA, it
can be concluded that the cellular DNA is not 5’s primary target
in the living cell.
Among the isolated STLs, compound 5 showed the strongest
cytotoxic activity, especially on murine SCVII as well as human
Caco-2 and HeLa cell lines, while no cytotoxic effect on normal
V79 fibroblasts was observed. Similar to the antibacterial activity,
a correlation between the cytotoxic activity and the type and
properties of the substituents on the central ring in the vicinity of
the α-methylene-γ-lactone group was observed. In comparison
to less lipophilic substituents of sesquiterpenes, as observed for
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FIGURE 10 | A summary of the most significant results obtained in this study.
6 and especially 4, the hydrophobic character of the isovalerate
residue of 5 most probably enables better penetration through
the cell membrane and consequently better antibacterial and
cytotoxic activity. In the literature, cytotoxic effects of various
STLs have been explained by selective alkylation of growth
regulatory macromolecules such as enzymes which control cell
division and thus a variety of cellular functions (Lyss et al., 1998;
Rasul et al., 2012).
Since compound 5 (ragusinin) showed the strongest activity
compared to other isolates and since the biological activity
of 5 was not described before we decided to investigate the
mechanism of its toxicity in more details. The IC50 value of
ragusinin was between 1.8 and 2.3 µM (Figure 6). This is
consistent with data from the literature, where compounds of
similar chemical structure, i.e., sesquiterpene lactones such as
helenalin (Gertsch et al., 2003), neoambrosin (Saeed et al.,
2015), and damsin (Villagomez et al., 2013), are reported to
be cytotoxic against various cell lines in the micromolar range.
Further analysis revealed time-dependent accumulation of HeLa
cells upon ragusinin treatment in the G2 phase and Sub G1
phase of the cell cycle (Figure 7B). But, the occurrence of
caspase and PARP cleavage independent cell death indicates
some alternative cell death pathway described in the literature
to be triggered by a different type of cell stressors (Kroemer
and Martin, 2005; Tait and Green, 2008). The phenomenon is
interesting to follow up further, especially because it is known
that helenalin, a STL isolated from Arnica montana, induces
the same atypical form of cell death which does not include
the activation of classical mediators of apoptosis (caspases,
AIF, Omi/HtrA2, and Apaf/apoptosome) (Hoffmann et al.,
2011).
In a series of noteworthy reports on the reactivity and
kinetics of helenalin and helenanolide type STLs with GSH,
it was demonstrated that at physiological pH helenalin reacts
with GSH almost exclusively via its cyclopentenone structure
while the α-methylene-γ-lactone site is less reactive (Schmidt
et al., 1999). Since the guajanolide 5 possesses one reactive
site, i.e., the α-methylene-γ-lactone group that can react
with GSH, we decided to investigate the role of GSH in
deactivation of 5.
From the literature is known that GSH is one of the major
endogenous antioxidants. In the cytoplasm, GSH is used as a
substrate for glutathione peroxidase in the reduction of H2O2
and lipid hydroxyperoxides, a reaction that produces glutathione
disulfide, the so-called oxidative form of GSH. Glutathione
disulfide is rapidly reduced to GSH by glutathione reductase. This
redox cycling of GSH plays a role in the maintenance of cellular
redox homeostasis. GSH binds to endogenous and diverse
xenobiotic electrophilic compounds either catalytically, through
the action of glutathione S-transferase, or non-catalytically
(Townsend and Tew, 2003; Brozovic et al., 2014). The formed
GSH conjugates can be exported from cells, resulting in the loss of
cellular GSH. Our data showed that variation of GSH amount in
the cell induced by a specific precursor in GSH synthesis, NAC or
a specific inhibitor of GSH synthesis, BSO had an impact on HeLa
survival upon treatment with 5 (Figure 8). Similar results were
obtained in human colon tumor cells upon BSO and helenalin
treatment (Jordan et al., 1987). Moreover, we showed that GSH
probably does not play a role as antioxidant (Supplementary
Figure S6) but rather as molecule which form conjugates with 5
increasing in that way the survival of HeLa cells upon treatment
with it (Figure 9).
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CONCLUSION
In this study, the most active compound has shown to
be a sesquiterpene lactone, ragusinin (compound 5) whose
biological activity has not been investigated so far. Currently, our
knowledge about the mechanism of action of STLs is still limited.
Several of them reached clinical trials due to their ability to trigger
cell death in tumor but not in normal cells (Zhou and Zhang,
2008; Kawasaki et al., 2009; Crespo-Ortiz and Wei, 2012).
Here we are showing for the first time the biological activity of
compound 5, ragusinin. Although ITC and CD results suggested
that the cellular DNA is not the primary target of ragusinin in the
living cell, these data represent valuable information since, to the
best of found knowledge, STL−DNA interactions have not been
communicated before.
The variation of the amount of GSH in the cell by using a
specific precursor in GSH synthesis (NAC) or a specific inhibitor
of GSH synthesis (BSO) showed the importance of GSH in the
cell’s response to 5. Moreover, it was shown that formation of
GSH-ragusinin conjugates increased cell survival what implies
the role in GSH detoxification rather than in stabilization of
the cell redox system. Ragusinin induced G2 arrest followed by
caspase-independent cell death.
Though the actual protein targets remain unclear at this
stage of the investigation, we can confirm that compound 5 is
deactivated by GSH resulting in a diminished cytotoxic effect.
A summary of the most significant results obtained in this
study by using specified techniques is presented in Figure 10.
In future studies, it will be interesting to investigate whether
ragusinin-GSH conjugates have a biological activity or whether
they are ejected from cells through so-called GSH pumps such as
MRP1 and MRP2 (Homolya et al., 2003).
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Phytochemical profiles of volatile constituents from Centaurea ragusina leaves
and flowers and their antimicrobial effects. Nat. Prod. Commun. 7, 1087–1090.
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